Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Respiratory Syncytial Virus
79%
Respiratory Syncytial Virus Infection
45%
Respiratory Syncytial Virus Bronchiolitis
30%
Lower Respiratory Tract Infection
22%
Wheezing
18%
Disease Severity
11%
Bronchiolitis
10%
Preterm Infants
9%
Netherlands
8%
Hospitalization
8%
Virus Diseases
8%
Children with Down Syndrome
7%
Recurrent Wheezing
7%
Interleukin-10
7%
Down Syndrome
6%
Palivizumab
6%
Respiratory Syncytial Virus Hospitalization
6%
Leukocytes
6%
Recurrent Wheeze
6%
Viral Infection
6%
Single nucleotide Polymorphism
5%
Respiratory Infection
5%
Toll-like
5%
Risk Factors
5%
Virus
5%
Gestational Age
5%
Asthma
5%
First Year of Life
5%
Inhibitory Receptors
5%
Immunology and Microbiology
Human Respiratory Syncytial Virus
100%
Respiratory Syncytial Virus Infection
42%
Bronchiolitis
30%
Lower Respiratory Tract
19%
Respiratory Syncytial Virus
10%
Asthma
8%
Interleukin 10
7%
Innate Immune System
6%
Infection
6%
Immune Response
6%
Infectious Agent
6%
Palivizumab
6%
Immunity
6%
Viral Disease
6%
Leukocyte
5%
Human Immunodeficiency Virus
5%
Intravenous Immunoglobulin
5%
Medicine and Dentistry
Human Respiratory Syncytial Virus
63%
Respiratory Syncytial Virus Infection
24%
Wheeze
23%
Bronchiolitis
18%
Lower Respiratory Tract Infection
15%
Respiratory Tract Infection
10%
Respiratory Syncytial Virus
9%
Disease
7%
Asthma
6%
Systematic Review
6%
Diseases
5%
Infection
5%
Lung
5%
Intensive Care Unit
5%
